About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, December 10th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

Liberated Energy, Inc. (LIBE)

PennyStocks24, Top Stock Tips, TheMicrocapNews, and WiseAlerts reported earlier on Liberated Energy, Inc. (LIBE), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Liberated Energy, Inc. is an alternative energy company based in Marlton, New Jersey. The Company looks to reduce the removing of the planet's resources through bringing patentable and affordable ideas to the market. Its first objective is to make small wind and solar turbine technology a major contributor to the worldwide clean energy supply portfolio. This is through providing consumers with an affordable renewable energy option for their homes and businesses. The Company recently acquired Perpetual Wind Power Corp. (PWPC).  Liberated Energy lists on the OTC Markets’ OTCQB.

In March of this year, Liberated Energy announced that via a partnership with Hemp, Inc. (HEMP), it will be expanding its alternative energy technologies into the industrial hemp industry. By working in tandem, Hemp and its subsidiaries will be able to provide new gateways of distribution for Liberated Energy's unique Guard Lite™ Security Lighting System and its other patent pending technologies.

Liberated Energy has patents pending for a ridgeline roof wind device, and the Guard Lite™. In addition, it is looking at other alternative energy products that it hopes to seek patents on and commercialize.

Liberated Energy entered into an agreement with Hemp’s “The Industrial Hemp and Medical Marijuana Consulting Company, Inc. “(IHMMCC) to help it market and distribute its alternative energy products in the Industrial Hemp and Medical Marijuana industries.

In July of this year, Liberated Energy announced that it signed a Letter of Intent (LOI) to Joint Venture with FutureWorld Corp. FutureWorld is a foremost provider of advanced solutions to the Cannabis industry internationally with its subsidiary HempTech. This will allow Liberated Energy to integrate CaNNaLyTiX™, SmartSense™, and SmartNergy™ with the Guard Lite™.

The Guard Lite™ uses wind and solar energy to power its security system. The system consists of a High Tech LED Lighting Wi-Fi HD Camera with 2 way audio Infrared and Motion Technology. The Guard Lite™ is self-powered. It will use only around 10 percent of its maximum rated wind and solar energy. Excess energy can be used for other electrical components. The design of the Guard Lite™ security lighting system is to deter trespassers from homes and/or properties - without electricity costs.

Liberated Energy, Inc. (LIBE), closed Wednesday's trading session at $0.01, down 9.09%, on 3,802,850 volume with 61 trades. The average volume for the last 60 days is 302,683 and the stock's 52-week low/high is $0.007/$0.40.

Global Arena Holding, Inc. (GAHC)

Real Pennies reported recently on Global Arena Holding, Inc. (GAHC), Greenbackers and Information Solutions Group did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Global Arena Holding, Inc. is a financial services firm that services the financial community by way of its subsidiaries. The Company established to consolidate, acquire, and/or merge with other operating FINRA broker/dealers, registered representatives, SEC Registered Investment Advisors, National Futures Associations Members, and Commodity Trading Advisors. Global Arena Holding’s shares trade on the OTC Markets’ OTCQB. The Company has its corporate headquarters in New York, New York.

Global Arena Holding provides retail brokerage services. This includes equities, corporate and municipal bonds, mutual funds, insurance products, and options. It also provides investment banking services consisting of mergers and acquisitions (M&A) advisory services, capital raising services, and valuation and fairness opinions.

Furthermore, it provides corporate finance and strategic advisory services to public, private, and emerging growth companies. In addition, the Company provides finance services to the entertainment industry. It also provides wealth management and investment management services. Moreover, Global Arena Holding concentrates on fixed income/public finance, as well as institutional sales and trading services.

At present, the Company owns four subsidiaries. These are Global Arena Capital Corp., Global Arena Investment Management LLC, MGA International Brokerage LLC, and Lillybell Entertainment LLC.

Global Arena Capital is a registered broker dealer. It clears its securities transactions on fully disclosed through the RBC Dain Correspondent Services, a division of RBC Dain Rauscher. Global Arena Holding entered into a purchase agreement on August 5, 2014, for an initial 24.9 percent and the remaining 75.1 percent upon FINRA approval.

Global Arena Investment Management is an SEC Registered Investment Advisor. This subsidiary (100 percent owned by Global Arena Holding) provides asset management through separately managed accounts at Fidelity Institutional Wealth Services.

The MGA International Brokerage subsidiary, which the Company owns 66.6 percent of, is a licensed Full-Service Insurance Broker. MGA provides a wide selection of insurance and risk management products and services. The Lillybell Entertainment subsidiary is an arts and entertainment finance company.

Global Arena Holding, Inc. (GAHC), closed Wednesday's trading session at $0.10, down 28.57%, on 1,928 volume with 3 trades. The average volume for the last 60 days is 2,325 and the stock's 52-week low/high is $0.0111/$0.5099.

Smack Sportswear, Inc. (SMAK)

OTCJournal, Pumps and Dumps, StockMarketQuote.us, and The Green Baron reported earlier on Smack Sportswear, Inc. (SMAK), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Smack Sportswear, Inc.’s commitment is to becoming a top brand and service provider to the indoor and sand volleyball markets. The Company is a foremost brand of custom apparel – chiefly centered on the sport of volleyball. Olympians and top professionals design and test many of Smack Sportswear’s garments.

Founded in 1994, the Company is based in Torrance, California and its shares trade on the OTC Bulletin Board. Its new management team has more than 45 years of experience in the team sports apparel market.

Smack Sportswear’s designs are of a style that mirrors the personality of Southern California. The Company offers styles to meet the requirements of any club or team. For women and men, Smack Sportswear offers sublimated jerseys, core jerseys, bottoms, warm-ups, as well as sand uniforms.

In Accessories, the Company offers socks, kneepads, and ankle braces. In addition, it offers backpacks and bags. In Team Apparel, Smack offers tees, fleece, warm-ups, headwear, and coaches’ apparel. Moreover, this winter, Smack Sportswear will launch an online uniform builder. This will allow teams to design and order their custom uniforms online.

This past September, Smack Sportswear announced the appointment of Mr. Christopher Jenks as the Chairman of the Board. Mr. Jenks has an extensive resume in the sporting goods/apparel industry. He has marketing and operating experience with a number of premier brands. These include Adidas, Sports Specialties (a division of Nike), Body Glove, and YKK.

At the same time, the Company announced the resignation of Smack Sportswear Chief Executive Officer, Mr. Bill Sigler. Mr. Sigler founded Smack Sportswear on the sands of Manhattan Beach, California in 1994. He has been the Company’s Chief Executive Officer since its establishment. He remains as a Board member. He will partner with Smack - as an independent distributor - to the hundreds of clubs and schools he has personally serviced over the last two decades.

Smack Sportswear, Inc. (SMAK), closed Wednesday's trading session at $0.075, down 6.25%, on 337,725 volume with 26 trades. The average volume for the last 60 days is 89,058 and the stock's 52-week low/high is $0.0065/$0.095.

Bullfrog Gold Corp. (BFGC)

PennyStocks24, Pumps and Dumps, StockLockandLoad, StockBomb.com, StockRockandRoll, PennyStockLocks.com, Liquid Pennies, Stockhunter.us, HEROSTOCKS, VIP STOCK ALERTS, and Stock Brain reported earlier on Bullfrog Gold Corp. (BFGC), and today we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Bullfrog Gold Corp. is a mineral exploration company that lists on the OTCQB. It has projects in Nevada and its executive management and technical teams are directed by Mr. David Beling, President and Chief Executive Officer (CEO). Mr. Beling has 49 years of experience with all stages of mineral exploration, mining and processing. This includes the engineering and management of 12 open pit mines, 9 underground mines, as well as 14 process plants for junior and major mining companies.

Bullfrog Gold aggressively continues to look for and selectively pursue acquisitions and potential business opportunities of merit. The Company has its headquarters in Grand Junction, Colorado.

Bullfrog Gold announced earlier the completion of a phase 1 drill program at its Klondike Silver Project located 40 miles north of Eureka, Nevada. Pertaining to the Company’s Klondike Exploration drilling and assaying, 1,507 feet of percussion drilling in 16 shallow holes and 2,885 feet of reverse circulation drilling in 11 deeper holes were completed by the end of May 2014.

The deepest hole was extended to 400 feet based on observations of mineralized host rocks in the drill cuttings. Significant oxide minerals of silver, lead, zinc, copper, and barite have been seen in the majority of the drill cuttings. Nevertheless, mineral contents in Klondike rocks can only be ascertained via assay.

In addition, Bullfrog Gold provided a 30-day termination notice on its Option to Purchase the Newsboy Gold Project positioned roughly 45 miles northwest of Phoenix, Arizona. This termination allows Bullfrog Gold to concentrate on exploring the substantial potential of Klondike while maintaining its 100 percent owned Bullfrog Gold Project located 120 miles northwest of Las Vegas, Nevada.

This past July, Bullfrog Gold announced results from the first drill program at the Klondike Silver Project. A significant intercept was drilled in the Copper Hill target, three new styles of mineralization were recognized, and the priority exploration targets have been further defined for drilling during a proposed phase 2 program.

The next program will include advance archeological clearances and approvals of all phase 2 holes to be drilled. The simultaneous completion of phase 1 reclamation requirements should also permit up to close to 5 acres of new disturbances during the phase 2 drill program.

Bullfrog Gold Corp. (BFGC), closed Wednesday's trading session at $0.014, down 17.65%, on 340,500 volume with 2 trades. The average volume for the last 60 days is 81,917 and the stock's 52-week low/high is $0.01/$0.165.

True Drinks Holdings, Inc. (TRUU)

MissionIR, SmallCapVoice, and Alliance Advisors reported earlier on True Drinks Holdings, Inc. (TRUU), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Irvine, California headquartered True Drinks Holdings, Inc. is a healthy beverage provider with major entertainment and media company licensing agreements for use of its characters on its proprietary, patented bottles. AquaBall™ Naturally Flavored Water is the Company's vitamin-enhanced water. True Drinks created AquaBall™ as a healthy alternative for children to drink.  AquaBall™ is now being sold into mass-market retailers throughout the United States True Drinks’ shares trade on the OTCQB.

AquaBall™ is a naturally flavored, vitamin-enhanced, zero-calorie, dye-free, sugar-free alternative to juice and soda. AquaBall™ contains no artificial colors or flavors. The product is enhanced with Vitamins B3, B5, B6, and B12 & C. In addition, AquaBall™ contains no high fructose corn syrup. It is sweetened with Stevia.  

Currently, AquaBall™ is available in four flavors. These are orange, grape, fruit punch and berry. True Drinks’ target consumers are children, young adults, and their guardians, who are attracted to the product by the entertainment and media characters on the bottle.

True Drinks announced a distribution partnership in 2013 with one of the world's largest grocery retailers, and the largest grocery chain in the United States, The Kroger Company, covering 31 states, over 2,400 grocery stores and approximately 800 convenience stores.

Regarding Energy Drinks, True Drinks has its Bazi All-Natural Energy drink with eight superfruits. Bazi All-Natural Energy is a 2-ounce blend of eight super-fruits, combined with D-Ribose. Bazi has no preservatives, lower calories, and naturally energizing antioxidants and powerful nutrients. Bazi contains 20 percent juice. Additionally, the Company’s development team is pursuing additional beverage products that will complement True Drinks’ current product lineup.

Last week, True Drinks Holdings reported that in November, it completed its largest month, surpassing $1 million in sales for the first time. The Company is creating demand in new markets via its new Direct Store Distributor (DSD) partners. This has resulted in incremental distribution, including more than 1,000 new retail locations in New York, New York. True Drinks is adding new DSD partners in the Midwest this month.

Furthermore, its Walmart sales have been progressively growing over the last eight weeks with units and store count trending upward. The Company’s revenues for the third quarter, ended September 30, 2014, were up 105 percent over the prior year period.

True Drinks Holdings, Inc. (TRUU), closed Wednesday's trading session at $0.225, down 0.62%, on 301,934 volume with 67 trades. The average volume for the last 60 days is 341,813 and the stock's 52-week low/high is $0.125/$0.53.

Tengion, Inc. (TNGN)

PennyStocks24, Equity Observer, Penny Dreamers, Value Penny Stocks, HotStockProfits, and Ascending Stocks reported earlier on Tengion, Inc. (TNGN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Tengion, Inc. is a clinical-stage regenerative medicine company that lists on the OTCQB. The Company is discovering and developing regenerative products. Tengion is concentrating its resources on large patient populations where the standard of care involves substantial costs and potentially complicated procedures with comorbidities that result in reduced quality of life and increased mortality. Tengion is headquartered in Winston-Salem, North Carolina.

The Company is focusing on developing its Organ Regeneration Platform™ to harness the intrinsic regenerative pathways of the body to regenerate a range of native-like organs and tissues. The goal is to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.

Using the Organ Regeneration Platform™, Tengion is pioneering the development of products consisting of a patient's own (autologous) regenerative cells, with or without a biocompatible material component, which are implanted into the body to engraft into, repair, or replace a damaged tissue or organ.

At present, Tengion is conducting Phase 1 clinical trials in Sweden and the U.S. for its Neo-Kidney Augment (NKA) cellular therapy. The intention of this is to prevent or delay dialysis and transplantation through increasing renal function in patients with advanced chronic kidney disease. A Phase 1 trial for Tengion’s Neo-Urinary Conduit has completed enrollment. The Company’s Neo-Urinary Conduit is an autologous implant. The intention of it is to catalyze regeneration of native-like urinary tissue for bladder cancer patients requiring a urinary diversion following bladder removal.

Tengion announced this past September that it, with the support of its Board of Directors, is exploring all strategic options to maximize the value of its assets. Tengion has retained Jefferies LLC as exclusive financial advisor to assist it with reviewing and structuring potential strategic transactions.

Tengion said that assuming it is able to obtain additional funding, it expects to enroll up to 15 and 12 patients, respectively, in the clinical trials in Sweden and the U.S. for its Neo-Kidney Augment (NKA) cellular therapy. The Company announced, in August 2014, encouraging six-month interim data for the first five patients with advanced CKD implanted in the Phase 1 clinical trial taking place at the Karolinska Institute in Stockholm, Sweden.

NKA cellular therapy was successfully implanted into one kidney of each patient. Tengion reported promising trends in the six-month data measurements of kidney function. This includes hemoglobin, serum creatinine, calculated estimated Glomerular Filtration Rate (eGFR), magnetic resonance imaging (MRI), and renal scintigraphy.

Tengion, Inc. (TNGN), closed Wednesday's trading session at $0.013, up 4.00%, on 62,950 volume with 5 trades. The average volume for the last 60 days is 268,008 and the stock's 52-week low/high is $0.008/$0.35.

iL2M International Corp. (ILIM)

PennyStockSpy, 007 Stock Chat, OtcShortReport, PennyStocks24, Investor Soup, Penny Stock Craze, Stock Preacher, Beacon Equity Research, Penny Stocks Finder, and SuperStockTips reported earlier on iL2M International Corp. (ILIM), and today we chose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, iL2M International Corp. operates as a music entertainment and social media business. It develops, creates, and markets iLink2Music.com, which is a social media platform. The Company is in beta to launch the iLink2Music.com digital media platform. iL2M International has its corporate head office in Burbank, California.

The Company is generating exclusive online celebrity radio, video, events, and content. It generates revenue from multi-sensory branding, content licensing and co-creation, and product placement by way of an immersive user experience.

Its iLink2Music.com enables users to unify their personal digital-mobile lifestyle, while at the same time providing exclusive global music entertainment content, networking, events, products, and services. Its platform allows the user to create a profile in the music entertainment zone that displays his/her talents or expertise.

In essence, iLink2Music.com is a user’s link to their personal digital lifestyle portal. It is a user’s web world, accessible through one screen. It is where users’ music, movies, games, sports, finance, shopping and all searches are tailored for them by them.

The platform features a fully customizable and personalized iLink2Music website designed by the user, as well as customized events tailored to one’s tastes. The platform also features access to celebrity merchandise; the ability to interact with one’s favorite brands and celebrities, and games and contests.

In addition, the platform features the ability to listen to, share and sell one’s own music. Furthermore, it features unlimited space for pictures, music, and more; live 24/7 most popular DJ streaming right to the user, exclusive tickets and offers exclusive to iLink2Music.com’s members, and live member events.

Recently, iL2M International announced that it appointed Mr. Chris Michael England as Director of Asian Business Development. He is the co-founder, Chief Executive Officer and Chairman of Nexus-arts B2B Solutions Ltd., which is a Hong Kong based business development agency. As the Director of Asian Business Development, he will work closely with iL2M International’s team to secure the Company’s long-term financial growth through setting and implementing strategic goals for the organization's social media platforms and enterprise in the Asian marketplace.

iL2M International Corp. (ILIM), closed Wednesday's trading session at $0.011, even for the day. The average volume for the last 60 days is 66,840 and the stock's 52-week low/high is $0.008/$1.43.

graphic

The QualityStocks
Company Corner

graphic
graphic

Nhale, Inc. (NHLE)

The QualityStocks Daily Newsletter would like to spotlight Nhale, Inc. (NHLE). Today, Nhale, Inc. closed trading at $0.56, off by 0.88%, on 56,376 volume with 43 trades. The stock’s average daily volume over the past 60 days is 43,505, and its 52-week low/high is $0.14/$1.33.

Nhale, Inc. noted today that, as the company and a licensed Washington pot producer move closer to signing a letter of intent (LOI), sales of recreational marijuana in the state continue to grow rapidly. Since the first recreational marijuana shops opened their doors in July, sales in Washington State have increased 400% and are on track to bring in about $200 million over the next 12 months, according to Marijuana Business Daily.

Nhale, Inc. (NHLE) develops and sells leading-edge technology in alignment with its mission to become a recognized, premier innovator in cannabis cultivation, dispensaries, testing and scientific products. Nhale explores innovations that will position the company on the front lines of the marijuana revolution.

Nhale is currently aggressively focused on grow operations in states where cannabis is legal, or soon to be legal, such as Oregon, Alaska and Florida. As an increasing number of states move towards legalization for medical or recreational use, growers are positioned to benefit from economies of scale due to escalating demand. Focusing on candidates in the cultivation space, Nhale is poised grow into a successful, sustainable enterprise through product or company acquisition in this explosive space.

Growpod, Nhale’s self-contained grow environment technology, is one of the company’s products and an entry point into the promising cultivation technology space. Growpod uses “controlled environment agriculture” to optimize plant development, plant quality and production efficiency in all climates and seasons.

Nhale believes innovation produces profitability, especially in growth-stage organizations entering emerging industries. This belief guides Nhale’s strong commitment to develop and commercialize cutting-edge consumer-oriented products primed for rapid commercialization. The company has identified strategic industry partnerships to support this growth objective and to secure an increasing footprint in the booming marijuana market. Disclaimer

Nhale, Inc. Company Blog

Nhale, Inc. News:

Recreational Pot Sales Posting Solid Gains as Nhale (NHLE) and Washington Grower Proceed With Negotiations

Nhale (NHLE) Submits LOI to Washington Marijuana Producer Following Financial Review

Nhale (NHLE) Working to Secure $10 Million in Financing

IFAN Financial, Inc. (IFAN)

The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.628, up 3.63%, on 657,092 volume with 273 trades. The stock’s average daily volume over the past 60 days is 389,835, and its 52-week low/high is $0.0114/$0.64.

IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.

Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.

Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.

IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer

IFAN Financial, Inc. Company Blog

IFAN Financial, Inc. News:

IFAN Financial, Inc. (IFAN) CEO Featured in Exclusive QualityStocks Interview

IFAN Financial, Inc. (IFAN) Announces Engagement of QualityStocks Investor Relations Services

IFAN Financial Acquires Mobile Payment Solutions Provider Mobicash America, Inc.

Cannabics Pharmaceuticals, Inc. (CNBX)

The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.25, even for the day, on 4,109 volume with 4 trades. The stock’s average daily volume over the past 60 days is 5,572, and its 52-week low/high is $0.03/$1.40.

Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.

Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.

The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.

Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer

Cannabics Pharmaceuticals, Inc. Company Blog

Cannabics Pharmaceuticals, Inc. News:

Cannabics Pharmaceuticals Signs IP Licensing and Collaboration Agreement in Spain

Cannabics Pharmaceuticals, Inc. (CNBX) Receives Cannabinoid R&D Lab Certification in Israel

Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.2499, even for the day, on 13,600 volume with 4 trades. The stock’s average daily volume over the past 60 days is 43,882, and its 52-week low/high is $0.12/$0.42.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Acquires Innovative Online Coupon Platform, CouBox

Mobile Lads Signs Reseller Agreement With Smart Mobile Rewards

Mobile Lads Signs Letter of Intent for Xtreme Mobility Software Acquisition

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $9.00, even for the day, on 10 volume with 1 trade. The stock’s average daily volume over the past 60 days is 267, and its 52-week low/high is $5.508/$15.00.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder

VistaGen Receives Notice of Allowance for Canadian Patent, Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

Falcon Crest Energy (FCEN)

The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.021, even for the day, on 800 volume with 1 trade. The stock’s average daily volume over the past 60 days is 27,671, and its 52-week low/high is $0.0005/$0.095.

Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Falcon Crest Energy Company Blog

Falcon Crest Energy News:

Falcon Crest Names Michael Cvetanovic to Advisory Council

Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition

Panther Energy Changes Name to Falcon Crest Energy

Technology Applications International, Inc. (NUUU)

The QualityStocks Daily Newsletter would like to spotlight Technology Applications International, Inc. (NUUU). Today, Technology Applications International, Inc. closed trading at $0.85, even with yesterday's close. The stock’s average daily volume over the past 60 days is 1,829, and its 52-week low/high is $0.10/$4.50.

Technology Applications International, Inc. (NUUU) is focused on producing, distributing, marketing and selling skincare products, in addition to engaging in the environmental management and water purification industries. The company conducts its business through two separate wholly owned subsidiaries: Rejuvel Int'l, Inc. and NueEarth, Inc.

Rejuvel Int'l, Inc. developed its skincare line of products using a NASA bioreactor to grow and expand three-dimensional fibroblast cells. Using exclusively licensed technology, licensed from the National Aeronautics and Space Administration and Administrators of the Tulane Educational Fund under U.S. Patent No. 6,730,498, the Rejuvel’s flagship anti-aging facial products trigger the multiplication of human fibroblast skin cells that rebuild skin for a firm, healthy and youthful appearance. The company has been awarded a “seal of approval” from the Space Certification program, setting a new standard for innovation in an industry projected to reach $114 billion in sales by 2015.

NueEarth, Inc. provides environmental management solutions and water purification techniques using a mobile electron beam accelerator unit which creates high-energy electrons that produce free radicals in the wastewater to decompose organic compounds or pollutants. The company has identified a number of different markets for this particle accelerator technology, including the removal of pollutants from wastewater, drinking water, municipal sludge and water that’s contaminated by the fracking process.

Technology Applications International’s management team is methodically establishing its brand in the marketplace with well-respected associations and strategic marketing initiatives. As the company continues to pursue direct consumer sales and other opportunities, it stands to do well with the foundation management has laid for growth. Disclaimer

Technology Applications International, Inc. Company Blog

Technology Applications International, Inc. News:

Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY® Awards Show at the MGM Grand in Las Vegas

Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Announced Today the Signing of a Distribution Agreement with Meditem Cyprus Limited

Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Expands its International Branding Efforts with Placements of Multiple Full Page Print Advertisements in International Fashion and Health Magazines

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyStockInformer
(RNTL)

2.

QualityStocks
(HEWA)

3.

Damn Good Penny Picks
(GEFI)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251